Reshape, a Copenhagen, Denmark–based AI and robotics-powered imaging and analysis platform provider, raised $20m in Series A funding.
The round was led by Astanor Ventures, R7, ACME, Y Combinator, Unity Co-Founder Nicholas Francis, and 21stBio.
The company intends to use the funds to expand its US operations and continue automating R&D for agricultural, industrial, and biotech organizations.
Founded in 2018 and led by Carl-Emil Grøn, CEO, Daniel Storgaard, and Magnus Nyborg Madsen, Reshape enables biological researchers to automate visual experiments by capturing and analyzing data points instantly and accurately. The solution empowers research labs to accelerate the pace towards scientific discoveries by minimizing errors and maximizing time for value-adding tasks, guiding microbiological research with precision towards a deeper understanding of nature. The company’s technology is already used by dozens of leading organizations including Syngenta, University of Oxford, Novozymes, and others who save more than 500,000 hours each year in manual research processes.
FinSMEs
09/04/2024